Avacta Group Plc - notizie pubblicate 143 - letture 5.220
AVACTA GROUP PLC
Avacta Selects Second pre|CISIONTM Pro-drug Candidate for Development
Avacta group plc (aim: avct), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary affimer® and pre| ...
AVACTA GROUP PLC
AffiDX® SARS-CoV-2 Antigen Lateral Flow Test Receives CE Mark for Consumer Self-Testing
Avacta group plc (aim: avct), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary affimer® and pre| ...
AVACTA GROUP PLC
Issue of Equity and Total Voting Rights
Avacta group plc (aim: avct), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary affimer® and pre| ...
AVACTA GROUP PLC
Change of auditor
Avacta group plc (aim: avct), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary affimer® and pre| ...
AVACTA GROUP PLC
Interview with Fiona McLaughlin – Avacta Chief Scientific Officer, Therapeutics
What attracted you to avacta? avacta is entering an exciting stage as a clinical development organisation, and i could see the potential to really shape the pipeline of its therape ...
AVACTA GROUP PLC
Interim Results for the Period Ended 30 June 2021 and Business Update
Transformative period for both diagnostics and therapeutics divisions avacta group plc (aim: avct), a clinical stage biopharmaceutical company developing innovative cancer therapie ...
AVACTA GROUP PLC
Achievement of Pre-clinical Development Milestone in LG Chem Life Sciences Partnership
Avacta group plc (aim: avct), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary affimer® and pre| ...
AVACTA GROUP PLC
Lateral Flow Assay Testing for COVID-19 – Tackling asymptomatic spread
Near the start of the covid-19 pandemic, the world health organisation (who) identified diagnostic testing as one of the key factors in monitoring and managing the spread of the di ...
AVACTA GROUP PLC
Notice of Results and Investor Presentation
Avacta group plc (aim: avct), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary affimer® and pre| ...
AVACTA GROUP PLC
Avacta announces new appointments to the Scientific Advisory Board of its Therapeutics Division
Avacta group plc (aim: avct), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary affimer® and pre| ...
AVACTA GROUP PLC
Appointment of Dr Fiona McLaughlin as Chief Scientific Officer of Avacta’s Therapeutics Division
Avacta group plc (aim: avct), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary affimer® and pre| ...
AVACTA GROUP PLC
Directorate Change
Avacta group plc (aim: avct), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative affimer® and pre|cision™ platforms, announces ...
AVACTA GROUP PLC
Result of Annual General Meeting
Avacta group plc (aim: avct), the developer of diagnostics and innovative cancer therapies based on its proprietary affimer® and pre|cision™ platforms, is pleased to announce th ...
AVACTA GROUP PLC
AffiDX® SARS-CoV-2 Antigen Lateral Flow Test Distribution Agreement
Avacta group plc (aim: avct), the developer of diagnostics and innovative cancer therapies based on its proprietary affimer® and pre|cision™ platforms, is pleased to announce th ...
AVACTA GROUP PLC
Posting of Annual Report and Notice of AGM
Avacta group plc (aim: avct), the developer of innovative cancer therapies and diagnostics based on its proprietary affimer® and pre|cision™ platforms, is pleased to announce th ...
Sei un professionista?
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti